BLCMEUR
Bellicum Pharmaceuticals Inc
A Houston-based biopharmaceutical company that engineers cellular immunotherapies, including CAR-T cell therapies, to treat cancers and blood disorders. Its technology includes GoCAR, designed to make engineered immune cells more effective, and CaspaCIDe, a built-in "kill switch" that lets doctors turn off the cells for safety. Founded in 2004 by physician-scientist Kevin Slawin, the company takes its name from the Latin "bellicum," meaning a military trumpet call that signals the start of battle—a fitting call to arms in the fight against cancer.
CUSIP: 079481404HealthcareUS2 holders
Total Value
$1.3K
Total Shares
150
Net Share Change
+101
Activity
2 buying
Investor
Value
Shares
Weight
Change
